Friday, 3rd of April 2015 |
HEPATITIS B VACCINATION DURING PREGNANCY FOR PREVENTING INFANT INFECTION
Sangkomkamhang US1, Lumbiganon P, Laopaiboon M.
Cochrane Database Syst Rev. 2014 Nov 11;11:CD007879. doi: 10.1002/14651858.CD007879.pub3.
Abstract
BACKGROUND:
Infant hepatitis B infection increases the risk of chronic infection, cirrhosis or liver cancer (hepatocellular carcinoma) in the adult. Perinatal transmission is a common route of infection.
OBJECTIVES:
To assess the effectiveness and adverse effects of hepatitis B vaccine administered to pregnant women for preventing hepatitis B virus infection in infants.
SEARCH METHODS:
We searched the Cochrane Pregnancy and Childbirth Groups Trials Register (31 August 2014).
SELECTION CRITERIA:
Randomized controlled trials (RCTs) assessing hepatitis B vaccination compared with placebo or no treatment during pregnancy for preventing infant infection. Quasi-RCTs and cross-over studies were not eligible for inclusion.
DATA COLLECTION AND ANALYSIS:
Two review authors independently assessed trials for inclusion. If any studies had been included, we planned to assess the risk of bias, extract data and check the data for accuracy of all included studies.
MAIN RESULTS:
We did not identify any studies for inclusion.
AUTHORS CONCLUSIONS:
We found no RCTs that assessed the effects of hepatitis B vaccine during pregnancy for preventing infant infection. Consequently, this review cannot provide guidance for clinical practice in this area. However, it does identify the need for well-designed randomized clinical trials to assess the effect of hepatitis B vaccine during pregnancy on the incidence of infant infection and to determine any adverse effects.
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
41196945 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |